Abstract
Epicardial adipose tissue (EAT) is a risk factor implicated in the pathogenesis and prognosis of cardiovascular disease. Metformin has been shown to regress EAT in animal models and observational studies. In this study, we report that metformin has no effect on EAT in patients with coronary artery disease without diabetes. • Epicardial adipose tissue is associated with the pathogenesis and prognosis of cardiovascular disease. • Metformin exhibits cardioprotective effects including anti-inflammatory properties. • Metformin treatment has no effect on epicardial adipose tissue compared with placebo in patients with coronary artery disease without type 2 diabetes.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
